{"id":2468,"date":"2020-09-25T10:07:44","date_gmt":"2020-09-25T15:07:44","guid":{"rendered":"http:\/\/nueva.idcbis.org.co\/?page_id=2468"},"modified":"2025-08-19T20:54:42","modified_gmt":"2025-08-20T01:54:42","slug":"unidad-de-terapias-avanzadas","status":"publish","type":"page","link":"https:\/\/idcbis.org.co\/en\/unidad-de-terapias-avanzadas\/","title":{"rendered":"Unidad de Terapias Avanzadas"},"content":{"rendered":"

<\/div><\/div>
<\/div>
\"Logo<\/div><\/div>
<\/p>\n

Investigation and development unit focused on the generation of new technologies in regenerative medicine based on advanced therapy (cell therapy, gene therapy and tissue engineering).<\/span><\/h1>\n

\n<\/div>

<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div>
<\/div>
<\/p>\n

The IDCBIS has highly trained human talent with knowledge in advanced cell therapy, currently has a unit called Advanced Therapies Unit (UTA) responsible for research and development of stem cell-based products for use at pre-clinical scale and in clinical trials. The ATU promotes the generation of knowledge and innovation in biomedical sciences through the articulation of actors in science and technology (public sector, academia and industry).<\/h3>\n

\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div>
\"Calidad<\/div><\/div>
<\/p>\n

We have a clean room that complies with GMP quality standards for the manufacture of cell therapy products.<\/h3>\n

\n<\/div>

<\/div><\/div><\/div>
<\/div>
\"Investigaci\u00f3n<\/div><\/div>
<\/p>\n

We lead a platform for research and development of mesenchymal stromal cell-based products for pre-clinical and clinical trial use.<\/h3>\n

\n<\/div>

<\/div><\/div><\/div>
<\/div>
\"icono<\/div><\/div>
<\/p>\n

We promote the generation of knowledge and innovation in biomedical sciences through the articulation of actors in science and technology (public sector, academia and industry).<\/h3>\n

\n<\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>
\"\"<\/div><\/div><\/div>
<\/div>
<\/p>\n

La secuenciaci\u00f3n de pr\u00f3xima generaci\u00f3n (NGS) permite la lectura masiva del material gen\u00e9tico y transcript\u00f3mico, facilitando el an\u00e1lisis de genomas, transcriptomas y epigenomas con alta precisi\u00f3n y eficiencia. Esta tecnolog\u00eda es clave para comprender procesos biol\u00f3gicos, identificar variantes gen\u00e9ticas y dise\u00f1ar terapias personalizadas.<\/p>\n

OmiMed es un laboratorio especializado en NGS, que pone al servicio de la comunidad acad\u00e9mica una plataforma integral para el desarrollo de ensayos en ciencias \u00f3micas y medicina personalizada que ofrece los siguientes servicios:<\/p>\n